Track topics on Twitter Track topics that are important to you
In a preclinical study, a small molecule drug, a selective tyrosine phosphatase inhibitor, has been shown to lift molecular “brakes” that normally slow the regeneration of blood stem cells following chemotherapy or radiotherapy. The inhibitor promotes the regeneration of murine and human hematopoietic stem cells capable of long-term hematopoietic reconstitution.
The post Drug Speeds Renewal of Blood Depleted by Chemo, Radiation appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Article: Drug Speeds Renewal of Blood Depleted by Chemo, RadiationNEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Track and monitor developments in stem cell research and commercial development. Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry. BioPort...